Eric Selander

Eric Selander holds extensive leadership experience in the pharmaceutical industry, currently serving as President of both SST Corporation and Lander Pharmaceuticals since 2019 and 2009, respectively. Previously, Eric occupied the role of CEO at Socorro Pharmaceuticals, LLC from 2017 to 2019, and Vice President of Business Development at CANDA Pharma LLC and ISC&P. Additional roles include Business Development at Apex Pharmaceuticals and Director of Business Development at Granules USA. Eric began a career at Pfizer as Team Leader-Inventory. Education was completed at West Virginia University from 1994 to 1999.